Why the Asaleo Care Ltd (ASX:AHY) share price has been crushed today

The Asaleo Care Ltd (ASX:AHY) share price has been crushed in early trade after downgrading its full-year guidance…

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

In morning trade the Asaleo Care Ltd (ASX: AHY) share price has plunged lower following the release of its preliminary half-year results and full-year guidance.

In early trade the personal care products company's shares are down a sizeable 34.5% to 85.5 cents.

What was in the update?

In the first-half of FY 2018 Asaleo Care expects to generate revenue of $267.2 million and underlying earnings before interest, tax, depreciation, and amortisation (EBITDA) of $46.3 million. This will be a decline of 9% and 24%, respectively, on the prior corresponding period.

A 39% decline in EBITDA from its Tissue segment has largely been behind the decline, though a 7% decline in Personal Care segment EBITDA also weighed on its results.

Management has blamed the poor result on higher pulp and electricity costs. In addition to this, the company experienced lower sales in its Tissue business because of price increases put in place to cover the cost increases. This led to reduced promotional activities with some customers and a significant loss of volume.

Compounding things further was an increased trade spend to support market share as heavy discounting from competitors weighed on its sales.

As a result of this weak first-half and the failure of initiatives put in place to improve its performance, management doesn't expect the company to achieve its prior guidance of underlying EBITDA in the range of $113 million and $119 million.

Management now expects underlying EBITDA in the range of $80 million to $85 million in FY 2018, a reduction of 29% from top to bottom.

Will things improve in FY 2019?

The company has undertaken a strategic review in response to the ongoing increases in input costs and challenging consumer market trading conditions.

The objective of this review is to design and implement the most efficient structure and business model to position Asaleo Care for sustainable long-term growth and to maximise its return on invested capital over the medium and long term.

While this could bring about an improvement in FY 2019, it certainly won't be an easy fix.

Asaleo Care has been on my avoid list for some time now and this remains the case today even after today's sizeable decline.

I would suggest investors look to other shares in the consumer space such as Blackmores Limited (ASX: BKL) or A2 Milk Company Ltd (ASX: A2M) instead.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Blackmores Limited. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Cochlear, Karoon Energy, Origin Energy, and WiseTech shares are falling today

These shares are starting the week in the red. Let's find out why.

Read more »

An arrow crashes through the ground as a businessman watches on.
Share Fallers

After falling 43% in a week, are Cochlear shares now a buy?

Is this drop a warning sign?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why Brainchip, Fortescue, IGO, and Life360 shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

a woman sits next to her computer screen with her head in her hands with the screens slowing graphs on downward trajectories.
52-Week Lows

Can the beaten-down CSL share price ever reach $300 again?

CSL is near decade lows. Can it ever climb back?

Read more »

An arrow crashes through the ground as a businessman watches on.
Healthcare Shares

Cochlear stock down 40%: How much has this cost ASX investors?

One day can ruin years of success...

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Black Cat, Mirvac, Qantas, and Temple & Webster shares are falling today

These shares are having a tough session. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Bank of Queensland, Cochlear, Northern Star, and Paladin Energy shares are falling today

These shares are having a difficult time on hump day. But why?

Read more »

An older man wearing glasses and a pink shirt sits back on his lounge with his hands behind his head and blowing air out of his cheeks.
Share Fallers

Why ANZ, Challenger, Hub24, and Lynas shares are dropping today

These shares are under pressure on Tuesday. But why?

Read more »